NCT04743986 (PRP) is a Phase 4 clinical trial of Platelet Rich Plasma (PRP) in Rotator Cuff Injuries, sponsored by University of Calgary.

Who is sponsoring NCT04743986?

NCT04743986 is sponsored by University of Calgary.

What drugs are being tested in NCT04743986?

Interventions in NCT04743986: Platelet Rich Plasma (PRP), Corticosteroid (CS).

What condition does NCT04743986 study?

NCT04743986 studies Rotator Cuff Injuries.

Is NCT04743986 still recruiting?

NCT04743986 is currently completed. Last updated 8 February 2021.

Last reviewed 2021-02-08 · How we verify

NCT04743986: PRP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial

Completed Phase 4 Last updated 8 February 2021

What this trial tests

Phase 4 trial testing Platelet Rich Plasma (PRP) in Rotator Cuff Injuries in 104 participants. Completed in 6 June 2019.

Timeline

13 March 2015

Primary endpoint
6 June 2019

6 June 2019

Quick facts

Lead sponsor	University of Calgary
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	104
Start date	13 March 2015
Primary completion	6 June 2019
Estimated completion	6 June 2019

Drugs / interventions tested

Platelet Rich Plasma (PRP) — full drug profile →
Corticosteroid (CS) — full drug profile →

Conditions studied

Rotator Cuff Injuries — all drugs for Rotator Cuff Injuries →

Sponsor

University of Calgary

Who can join

18 and older, any sex, with Rotator Cuff Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial examining platelet rich plasma versus corticosteroid injection in partial thickness rotator cuff tears or tendinopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet Rich Plasma (PRP)

Trials testing the same drug.

NCT05048667 — Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction · Phase 1 · completed
NCT04775004 — Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial) · NA · active not recruiting
NCT07410208 — Effect of PRP With Physiotherapy on Shoulder Impingement · NA · completed
NCT04452734 — Efficacy of Platelet Rich Plasma (PRP) on Mouth Opening and Pain After Surgical Extraction of Mandibular Third Molars. · NA · completed
NCT06481046 — Treatment of Rotator Cuff Tears With Platelet Rich Plasma · NA · withdrawn

Other recruiting trials for Rotator Cuff Injuries

Currently open trials in the same condition.

NCT07501013 — Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries · recruiting
NCT07294729 — Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions · NA · active not recruiting
NCT07135375 — Postoperative Rotator Cuff Rehabilitation: Functional, Pain and Sleep Quality · NA · recruiting
NCT07348016 — Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuf · NA · recruiting
NCT07228936 — The Role of Pectoralis Minor Tightness in the Development of Rotator Cuff Tears · recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04743986 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 8 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04743986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing